Home/Filings/4/0001127602-13-015046
4//SEC Filing

BOYER HERBERT W PH D 4

Accession 0001127602-13-015046

CIK 0000850693other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 8:16 PM ET

Size

14.4 KB

Accession

0001127602-13-015046

Insider Transaction Report

Form 4
Period: 2013-04-29
Transactions
  • Exercise/Conversion

    Common Stock

    2013-05-01+18,22523,035 total
  • Award

    Phantom Stock Units

    2013-04-29$113.68/sh+13.19$1,49918,190.01 total
    Common Stock (13.19 underlying)
  • Award

    Phantom Stock Units

    2013-04-30$113.55/sh+22.02$2,50018,225.22 total
    Common Stock (22.02 underlying)
  • Exercise/Conversion

    Phantom Stock Units

    2013-05-0118,2250 total
    Common Stock (18,225 underlying)
  • Award

    Phantom Stock Units

    2013-04-29$113.68/sh+13.19$1,49918,203.2 total
    Common Stock (13.19 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    9,600
Footnotes (6)
  • [F1]On May 1, 2013, 18,225 of the reporting person's Phantom Stock Units were settled for an equal number of shares of Allergan, Inc. common stock due to the reporting person's retirement as a director of Allergan, Inc. on April 30, 2013.
  • [F2]Includes shares acquired pursuant to dividend equivalent rights attached to RSU previously granted to the Report Person.
  • [F3]Shares held by the Herbert W. and Marigrace Boyer Living Trust U/A Restated August 3, 1995. Reporting person, along with his spouse, is co-trustee and co-beneficiary of the Trust.
  • [F4]Converts to common stock on a 1-for-1 basis.
  • [F5]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F6]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. Director.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeother

Related Parties

1
  • filerCIK 0001016351

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 8:16 PM ET
Size
14.4 KB